The Emerging Danger of Over-Medicating Youth Mental Health Problems in America

Photo byfreepik.com

The Diagnostic Dilemma

Based on current diagnostic criteria of mental health disorders, it has been estimated that half of all youngsters will face a diagnosable mental health disorder by the time they reach 18.

The primary response? A medical prescription. But such drugs may be doing more harm than good if the diagnosis is actually unnecessary.

However, relief often accompanies a mental disorder diagnosis, providing a semblance of understanding and control. But the ground reality is starkly different. The criteria for these diagnoses are subjective at best.

This leads to a disconcerting carousel of labels that can fundamentally alter a young person's self-perception and potential. During the formative teenage years, these labels don't just stick; they mold and shape identities, often to detrimental effect.

The Over-Medication Crisis

The American predilection for medicating young individuals is unparalleled worldwide. As of 2021, over six million (1 in 12) youths were medicated for a range of psychiatric conditions. This trend has only intensified post-pandemic, with prescriptions skyrocketing rather than merely increasing.

The assumption might be that such widespread medication is underpinned by solid scientific evidence. Unfortunately, this is far from the truth.

The safety and efficacy of these drugs, particularly SSRIs, in the developing brains of teens, remain largely an enigma. Long-term research indicates that these medications might not only be ineffectual but, in some cases, worse than no treatment at all.

Regarding the use of antidepressants, the Food and Drug Administration (FDA) has implemented a "black box" warning for healthcare providers. This is essentially a stringent cautionary alert due to findings suggesting an elevated risk of suicide among young individuals taking these medications.

Studies involving young individuals on antidepressants have identified a condition referred to as "serotonin syndrome," which encompasses a range of adverse effects like nausea, dry mouth, headaches, dizziness, excessive sweating, sleep disturbances, agitation, mania, hallucinations, confusion, tremors, and changes in consciousness.

But these symptoms are frequently misinterpreted as indications of a deteriorating illness, leading to a common response of increasing the dosage or prescribing additional medications.

This issue is further exacerbated by the pharmaceutical industry's pervasive influence, shaping perceptions of mental health through funding, advertising, and educational materials. The narrative pushed forward is one that emphasizes internal dysfunction treatable by their products.

Alternatives to Medication

The issue isn't the absence of effective treatments for depression and other psychiatric disorders. In fact, numerous types of psychotherapy, such as cognitive-behavioral therapies and mindfulness-based methods, have been proven to be both safe and beneficial.

Research even suggests that these therapeutic approaches can be more effective than medications for serious mental health conditions like schizophrenia.

As a society, we must recalibrate our approach to youth mental health, moving away from a diagnostic and medication-first paradigm. The current path is fraught with misdiagnosis, overmedication, and a disturbingly narrow view of mental health that negates the complex interplay of environmental, biological, and personal factors.